NanoViricides Inc. (NNVC)

[arvitar]

It does make one wonder about the nine animal studies and two human clinical trials that were supposed to be ongoing in 2014.

Or the studies from Wisconsin, Pittsburgh, Baylor, and St Jude that were to have been completed a year ago.

100% of everything NNVC has started over these past 12.5 years out has so far gone POOF!!!

In any case, maybe Seymour can figure out how to monetize meeting abstracts about cell culture studies to delay insolvency.


August 2013: " The company currently has nine products in its pipeline currently undergoing animal testing, with its influenza drug FluCide and Dengue fever drug DengueCide approaching currently approaching human clinical trials.

“This is a unique technology and this far, we have gotten patents in 25 countries with 100 expected by the end of the year,” Seymour said. “Every single large pharma has expressed an interest in our technology but they all want to wait until we're in humans next year before proposing a licensing deal.”
http://www.biopharma-reporter.com/Upstream-Processing/NanoViricides-Builds-Plant-to-Prep-for-Viral-Penicillin-Pipeline